Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
2.240
-0.050 (-2.18%)
Official Closing Price
Updated: 1:15 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
420,675
Open
2.310
Bid (Size)
2.230 (2,500)
Ask (Size)
2.300 (7,900)
Prev. Close
2.290
Today's Range
2.230 - 2.338
52wk Range
0.6110 - 11.57
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics to Participate in Upcoming Conferences in November
November 03, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+13.7%
+13.7%
1 Month
-23.5%
-23.5%
3 Month
+28.7%
+28.7%
6 Month
+199.5%
+199.5%
1 Year
-77.5%
-77.5%
More News
Read More
Unusual volume stocks in Thursday's session
↗
October 30, 2025
Via
Chartmill
Unusual volume stocks in Wednesday's session
↗
October 29, 2025
Via
Chartmill
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 27, 2025
Via
Benzinga
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
October 27, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies
↗
October 27, 2025
Via
Stocktwits
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
October 27, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 23, 2025
Via
Benzinga
Neumora Therapeutics to Host Virtual R&D Day on October 27
October 01, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
September 16, 2025
Via
Benzinga
Neumora Therapeutics to Participate in Upcoming Conferences in September
September 02, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora (NMRA) Q2 Loss Improves 10%
↗
August 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 28, 2025
Via
Benzinga
Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday
↗
July 25, 2025
Via
Benzinga
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 23, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 18, 2025
Via
Benzinga
These stocks are moving in today's session
↗
July 09, 2025
Via
Chartmill
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
July 09, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
June 09, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 19, 2025
Via
Benzinga
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Neumora Therapeutics, Inc. - Common Stock publicly traded?
Yes, Neumora Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Neumora Therapeutics, Inc. - Common Stock trade on?
Neumora Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neumora Therapeutics, Inc. - Common Stock?
The ticker symbol for Neumora Therapeutics, Inc. - Common Stock is NMRA on the Nasdaq Stock Market
What is the current price of Neumora Therapeutics, Inc. - Common Stock?
The current price of Neumora Therapeutics, Inc. - Common Stock is 2.240
When was Neumora Therapeutics, Inc. - Common Stock last traded?
The last trade of Neumora Therapeutics, Inc. - Common Stock was at 11/28/25 01:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.